Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review
Open Access
- 11 April 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (8) , 3305-3314
Abstract
Accurate and reliable assessment of kidney quality before transplantation is needed to predict recipient outcomes and to optimize management and allocation of the allograft. The aim of this study was to systematically review the published literature on biomarkers in two mediums (the perfusate from deceased-donor kidneys receiving machine perfusion and deceased-donor urine) that were evaluated for their possible association with outcomes after kidney transplantation. We searched the Ovid Medline and Scopus databases using broad keywords related to deceased-donor biomarkers in kidney transplantation (limited to humans and the English language). Studies were included if they involved deceased-donor kidneys, measured perfusate or urine biomarkers and studied a possible relationship between biomarker concentrations and kidney allograft outcomes. Each included article was assessed for methodological quality. Of 1430 abstracts screened, 29 studies met the inclusion criteria. Of these, 23 were studies of perfusate (16 biomarkers examined) and 6 were studies of urine (18 biomarkers examined). Only 3 studies (two perfusate) met the criteria of ‘good’ quality and only 12 were published since 2000. Perfusate lactate dehydrogenase, glutathione-S-transferase (GST) and aspartate transaminase were all found to be significantly associated with delayed graft function in a majority of their respective studies (6/9, 4/6 and 2/2 studies, respectively). Urine neutrophil gelatinase-associated lipocalin, GST, Trolox-equivalent antioxidant capacity and kidney injury molecule-1 were found to be significantly associated with allograft outcomes in single studies that examined diverse end points. Higher quality studies are needed to investigate modern kidney injury biomarkers, to validate novel biomarkers in larger donor populations and to determine the incremental predictive value of biomarkers over traditional clinical variables.Keywords
This publication has 77 references indexed in Scilit:
- A Simple Tool to Predict Outcomes After Kidney TransplantAmerican Journal of Kidney Diseases, 2010
- The Prognostic Utility of Deceased Donor Implantation Biopsy in Determining Function and Graft Survival After Kidney TransplantationTransplantation, 2010
- The Alphabet Soup of Kidney TransplantationClinical Journal of the American Society of Nephrology, 2009
- The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic modelHealth Technology Assessment, 2009
- A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk IndexTransplantation, 2009
- Kidney Injury Molecule-1 is an Early Noninvasive Indicator for Donor Brain Death-Induced Injury Prior to Kidney TransplantationAmerican Journal of Transplantation, 2009
- “Nature versus Nurture” Study of Deceased-Donor Pairs in Kidney TransplantationJournal of the American Society of Nephrology, 2009
- Organ Donation and Utilization in the United States: 1998–2007American Journal of Transplantation, 2009
- The Maryland Aggregate Pathology Index: A Deceased Donor Kidney Biopsy Scoring System for Predicting Graft FailureAmerican Journal of Transplantation, 2008
- Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysisNephrology Dialysis Transplantation, 2008